Professional Documents
Culture Documents
Starcef 2023
Starcef 2023
2023
IMS 2Q’22 Sales
Scenario
Cephalosporin Molecules
Sales (Cr.) Share Growth
CEPHALOSPORINS 1822.68 100.00 -1.00
CEFUROXIME 780.46 42.82 -1.12
CEFIXIME 647.64 35.53 4.54
CEFTRIAXONE 200.41 11.00 -5.71
CEFRADINE 65.12 3.57 -16.97
CEFTIBUTEN 54.26 2.98 -10.84
CEFACLOR 19.10 1.05 -1.53
CEFADROXIL 15.28 0.84 -10.67
CEFPODOXIME 12.25 0.67 -3.38
CEFTAZIDIME 7.94 0.44 -0.03
CEFDITOREN PIVOXIL 5.36 0.29 24.35
CEFOPERAZONE 3.44 0.19 11.74
CEFEPIME 3.07 0.17 -12.37
IMS 2Q’22- Cefixime Sales
Contribution
Capsule & PFS
2023 11 cr.
Objective
2023
PFS Capsule
Avg. monthly target: 19700 Phial Avg. monthly target: 14700 Box
CA/RMO/
Pediatrician GP, Medicine Gynae Surgery
Intern
Drug of choice for Typhoid fever & Ideal Choice for Superior in UTI due Ideal Choice for
Pediatric infection Pneumonia Switch therapy to better gram- Switch therapy
negative bacterial with Ceftriaxone
coverage
Pediatrician development Program
Institute Chamber
DHAKA SHISHU
MIRPUR SHISHU
JATRABARI SHISHU
DMCH CHAMBER DOCTOR
SSMCH
ShSMCH
BSMMU
Development
(Coxs bazar/Sylhet)
Target
100 Pediatrician
Customer
Short Brief of
Dinner with pediatrician (selected)
Program
Pediatrician development
Program
Nitrogen Purging
demonstration
Target
300 Pediatrician
Customer
We will demonstrate our PFS for
Short Brief of describing nitrogen purging
Program technology with video and
customized bag
Pediatrician development
Program
Nitrogen Purging CME in Child
Hospital
Target
All child Hospital
Customer
Target
Pediatrician
Customer
Toys campaign
Toys in
Chamber
Pediatrician development
Program
Story writing competition
for child
Short Brief of
We will arrange story writing competition
Program
Short Brief of
Gift in every quarter
Program
THC/ Sadar Hospital Emergency
Campaign
•Educational Customized
Period Jan-Dec 2023
support like food box for
BCS books for doctor
Objective Focus on Discharge Rx from Clinic BCS candidate
1350
Doctor
Rx Championship Campaign
(Region)
Doctor Total % of
Brand Target PPM Gift
developments expenses Expense